New injection treatment tested for blinding eye inflammation
NCT ID NCT02931175
Summary
This study tested whether injections of ACTH gel could help control non-infectious uveitis, a serious inflammatory eye disease that can lead to blindness. Twenty-eight patients with active or recently active uveitis received injections either two or three times per week for six months, followed by treatment as needed. Researchers measured whether the treatment reduced eye inflammation and improved vision while monitoring for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Metropolitan Eye Research and surgery Institute
Waltham, Massachusetts, 02451, United States
-
Retina Centers Professional Corporation - RCPC
Cleveland, Ohio, 44139, United States
-
Retina Consultants of Houston
Bellaire, Texas, 77401, United States
-
Retina Vitreous Associates, Medical Group
Los Angeles, California, 90017, United States
-
Stanford University
Palo Alto, California, 94303, United States
-
TExas Retina Associates
Dallas, Texas, 75231, United States
-
Texas Retina Assiciates
Dallas, Texas, 75231, United States
Conditions
Explore the condition pages connected to this study.